FR1041M - Nouvelles compositions pharmaceutiques contenant la 5-5-diphényltétrahydrogloxaline-4-one. - Google Patents

Nouvelles compositions pharmaceutiques contenant la 5-5-diphényltétrahydrogloxaline-4-one.

Info

Publication number
FR1041M
FR1041M FR857849A FR857849A FR1041M FR 1041 M FR1041 M FR 1041M FR 857849 A FR857849 A FR 857849A FR 857849 A FR857849 A FR 857849A FR 1041 M FR1041 M FR 1041M
Authority
FR
France
Prior art keywords
diphenyltetrahydrogloxaline
pharmaceutical compositions
compositions containing
new pharmaceutical
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR857849A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Organisation de Synthese Mondiale Orsymonde SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organisation de Synthese Mondiale Orsymonde SA filed Critical Organisation de Synthese Mondiale Orsymonde SA
Application granted granted Critical
Publication of FR1041M publication Critical patent/FR1041M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR857849A 1960-05-03 1961-04-06 Nouvelles compositions pharmaceutiques contenant la 5-5-diphényltétrahydrogloxaline-4-one. Expired FR1041M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1559360A GB904104A (en) 1960-05-03 1960-05-03 Pharmaceutical compositions containing 5,5-diphenyl-tetrahydroglyoxaline-4-one

Publications (1)

Publication Number Publication Date
FR1041M true FR1041M (fr) 1962-02-02

Family

ID=10061913

Family Applications (1)

Application Number Title Priority Date Filing Date
FR857849A Expired FR1041M (fr) 1960-05-03 1961-04-06 Nouvelles compositions pharmaceutiques contenant la 5-5-diphényltétrahydrogloxaline-4-one.

Country Status (3)

Country Link
BE (1) BE602303A (fr)
FR (1) FR1041M (fr)
GB (1) GB904104A (fr)

Also Published As

Publication number Publication date
GB904104A (en) 1962-08-22
BE602303A (fr) 1961-07-31

Similar Documents

Publication Publication Date Title
OA00788A (fr) Nouvelles compositions thermoplastiques.
BE765108A (fr) Nouvelles compositions desinfectantes
FR2144M (fr) Compositions pharmaceutiques contenant des sources radioactives.
FR2517M (fr) Compositions pharmaceutiques contenant des propanolamines.
BE604839A (fr) Nouvelles substances vaso-dilatatrices.
FR1522M (fr) Nouvelles diphényléthylamines substituées.
FR1715M (fr) Composition thérapeutique.
FR3207M (fr) Nouvelles substances médicamenteuses et compositions les contenant.
FR928M (fr) Composition antituberculeuse
BE600388A (fr) Compositions antituberculeuses
FR1045M (fr) Compositions anorexigéniques.
FR1041M (fr) Nouvelles compositions pharmaceutiques contenant la 5-5-diphényltétrahydrogloxaline-4-one.
DK106083C (da) Aksialtapleje.
FR1271M (fr) Nouvelles compositions pharmaceutiques.
FR1004M (fr) Composition hypnotique et tranquillisante contenant la 4,6-diméthylpyridazone-3.
FR2557M (fr) Composition pharmaceutique.
FR3376M (fr) Compositions pharmaceutiques contenant des dérivés de la quinoléine.
FR2156M (fr) Nouvelles compositions thérapeutiques.
FR3054M (fr) Préparations pharmaceutiques.
FR208M (fr) Nouvelles n-phénylpipérazines, et compositions pharmaceutiques qui les contiennent.
FR3650M (fr) Nouvelles compositions pharmaceutiques de caoutchoue silicone contenant des elements et composés radio-actifs.
FR1258482A (fr) Essences contenant des additifs polymérisés
BE757085A (fr) Nouvelles compositions pharmaceutiques
BE609487A (fr) Nouvelles compositions .
BE585967A (fr) Compositions pharmaceutiques contenant des dérivés de la benzylhydrazine.